Home » Topics » BioWorld Science

BioWorld Science
RSS

Tegsedi approved in the E.U. for the treatment of hATTR

July 12, 2018

Ovid Therapeutics initiates phase II ROCKET trial of OV-101 in fragile X syndrome

July 12, 2018

BioSight receives clearance to initiate phase IIb study of BST-236 in AML

July 12, 2018

[225Ac]DOTA-PEG7-5B1 as pretargeted radioimmunotherapy for pancreatic ductal adenocarcinoma

July 12, 2018

Investigating isoflavonoids for the potential treatment of obesity and diabetes

July 12, 2018

FDA clears IND for Adagene's phase I study of ADG-106

July 12, 2018

Researchers develop a rat model of diabetic cardiomyopathy for cardiovascular evaluation

July 12, 2018

Achillion initiates first-in-human study of ACH-5548

July 12, 2018

Feeding findings may hold key to appetite control

July 12, 2018

Novel TZD CMHX-008 maintains insulin sensitization with minor effects on weight gain and bone loss

July 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...